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Stem cell transplants offer significant hope for brain
repair following ischemic damage. Pre-clinical work
suggests that therapeutic mechanisms may be
multi-faceted, incorporating bone-fide circuit recon-
struction by transplanted neurons, but also protec-
tion/regeneration of host circuitry. Here, we engi-
neered hydrogel scaffolds to form ‘‘bio-bridges’’
within the necrotic lesion cavity, providing physical
and trophic support to transplanted human embry-
onic stem cell-derived cortical progenitors, as well
as residual host neurons. Scaffolds were fabricated
by the self-assembly ofpeptides for a laminin-derived
epitope (IKVAV), thereby mimicking the brain’s major
extracellular protein. Following focal ischemia in rats,
scaffold-supported cell transplants inducedprogres-
sive motor improvements over 9 months, compared
to cell- or scaffold-only implants. These grafts were
larger, exhibited greater neuronal differentiation,
and showed enhanced electrophysiological proper-
ties reflective of mature, integrated neurons. Varying
graft timing post-injury enabled us to attribute repair
to both neuroprotection and circuit replacement.
These findings highlight strategies to improve the
efficiency of stem cell grafts for brain repair.INTRODUCTION
Loss of neurons in the cerebral cortex underlies much of the mo-
tor, sensory, and cognitive dysfunction in stroke patients, with
disability due to primary neuronal loss, as well as additional
ongoing secondary degeneration in the surrounding penumbra
(Lindvall and Kokaia, 2011). With the exception of surgical clot
removal or thrombolytic drugs, both targeted at restoring
perfusion and penumbral protection, no effective treatment is
currently available to improve functional recovery in patients1964 Cell Reports 20, 1964–1977, August 22, 2017 ª 2017 The Autho
This is an open access article under the CC BY-NC-ND license (http://(Lindvall and Kokaia, 2011). Circuit replacement, through trans-
plantation of neural progenitor cells (NPCs) generated from
pluripotent stem cells (PSCs), represents a hopeful and realistic
therapeutic strategy.
Clinical proof-of-principle for this approach is drawn from
Parkinson’s disease patient trials where transplanted dopamine
neurons reinnervate the denervated striatum, resulting in sus-
tained improvement of motor function (Barker et al., 2013). A
fundamental requirement for therapeutic efficacy is the correct
specification of transplanted neurons in order to facilitate
functional innervation of appropriate targets (Thompson and
Bjo¨rklund, 2012).
For acute brain injuries, including ischemic stroke, the require-
ment for functional connectivity is less clear. Pre-clinical studies
have demonstrated therapeutic benefits associated with trans-
plant-mediated effects on host tissue including penumbral pro-
tection, enhanced angiogenesis, modulation of inflammation,
and stimulation of compensatory plasticity (Lindvall and Kokaia,
2011). This has stimulated interest in the use of non-neural cells,
such as mesenchymal stem cells, as donor-cell preparations
aimed squarely at conferring benefit through these homeostatic
mechanisms (Cao and Li, 2015). While promising, functional re-
covery is often incomplete and may be limited by extensive non-
recoverabledamage.Thus, additional functional recovery through
bona-fide circuit reconstruction remains a promising strategy.
PSCs hold significant potential as a donor source for cell
replacement in stroke. Routine procedures now exist for gener-
ating a diverse range of neuronal subtypes, including specifica-
tion into cortical projection neurons (Shi et al., 2012; Chambers
et al., 2009) relevant for replacement of cortical circuitry
damaged after stroke. Following transplantation, PSC-derived
neurons exhibit a remarkable capacity for long-range anatomical
integration and development of appropriate electrophysiological
properties (Denham et al., 2012; Espuny-Camacho et al., 2013;
Niclis et al., 2017b; Steinbeck et al., 2012). In rodent models of
stroke, various degrees of functional recovery have been re-
ported (Daadi et al., 2008; Gomi et al., 2012; Jensen et al.,
2013; Jiang et al., 2011; Oki et al., 2012; Qin et al., 2013; Tatar-
ishvili et al., 2014; Tornero et al., 2013), but over time frames
inconsistent with functional maturity of implanted neurons.rs.
creativecommons.org/licenses/by-nc-nd/4.0/).
Thus, direct contribution to functional neuronal replacement has
been difficult to assess.
Long-term survival and integration of grafted neurons may be
particularly challenging in a stroke-affected hostile environment
characterized by a cystic cavity, highly vulnerable peri-infarct tis-
sue,andproinflammatorycues (Jendelova´etal., 2016).Useofbio-
materials is increasingly being recognized as a valuable adjunct
approach for cell-based therapies and may impart physical and
trophic support to both host and grafted cells (Jendelova´ et al.,
2016). A variety of natural and synthetic polymers, such as
collagen, chitosan, and poly(lactic acid), as well as decellularized
scaffolds, have been employed to support neural grafts in the
ischemic brain (Bible et al., 2009, 2012; Cheng et al., 2013; Elias
and Spector, 2012; Jin et al., 2010; Liang et al., 2013; Park et al.,
2002; Yu et al., 2010; Zhong et al., 2010). While these materials
have shown variable anatomical and functional benefits, most
optimal for regenerative medicine will be the employment of
readily injectable nanomaterials that self-assemble from biologi-
cally active molecules. Few studies have examined the potential
for synthetic, but biomimetic, self-assembling peptide (SAP) scaf-
folds with transplantation and have focused on endogenous
neuron survival and plasticity (Ellis-Behnke et al., 2006; Guo
etal., 2009).Here,we report theuseofan injectablebiological sub-
strate that facilitates long-term survival and functional maturation
of human PSC (hPSC)-derived cortical neurons, when implanted
into thesiteofcortical ischemic.Wereport this functionalizedscaf-
fold restored tissue architecture within the lesion cavity, reduced
atrophy and cell loss within the penumbra, while additionally sup-
ported cortical neuronal differentiation of humanPSCgrafts. Scaf-
fold-supported transplantswere capable of prolonged restoration
of motor function, providing evidence of sustained benefits of hu-
man stem cells and biomaterials in repair of the ischemic brain.
RESULTS
Characterization of Peptide-Based Scaffolds and Stem
Cell Differentiation
To rebuild the local architecture at the primary injury site and
support the integration of grafts into the surrounding host tissue,
we tailored a biomaterial to provide structural scaffolding and
biomimetic of the brain’s extracellular matrix. The synthesized
scaffold incorporated the laminin binding domain peptide
sequence, IKVAV, necessary for neural adhesion, migration, dif-
ferentiation, and axonal plasticity (Matson et al., 2011). SAPs
were optimized for assembly at pH 7.4, by adjustment of the
pKa, through the addition of two aspartate residues, giving the
resultant peptide sequence DDIKVAV (Figure 1A). Aromatic fluo-
renylmethyloxycarbonyl (Fmoc) moieties were used to protect
the amino terminus of the peptide and provide shared electrons
to form p-p interactions, creating a backbone structure (Figures
1A and 1B, red). The individual peptides interacted via hydrogen
bonds to form secondary protein b sheets (Figure 1C), confirmed
by spectroscopic analysis (Figures 1F and 1G). Through a com-
bination of amphiphilic organization, p-p interactions, and b
sheets, nanotubes were formed (Figure 1D) that interacted to
create highly hydrated bundles and provided the underlying ma-
trix (Figure 1E). Nanofibrous structure was confirmed via electron
microscopy (Figure 1H), while rheological analysis validatedviscoelastic gel properties, demonstrating that the resultant hy-
drogel had a modulus not dissimilar to the rat brain (Figure 1I)
and was thereby suitable for brain repair.
Cortical progenitors were generated via dual SMAD inhibition
of hPSCs, resulting in neural induction and dorsal forebrain
specification, as shown by the presence of rosettes and neu-
ral-ridge structures at 10 days in vitro (DIV) and expression of
the NPC marker SOX2, dorsal telencephalic marker PAX6, and
forebrain/midbrain transcription factor OTX2 (Figures 1J and
1K). These forebrain progenitors, expanded as neurospheres,
showed maintained GFP, OTX2, and Nestin expression at the
time of transplantation (Figures 1L and 1M, 17 DIV).
SAP-Supported Neural Grafts Improve Sensorimotor
Function in Ischemic Rats
Staircase testing of fine and coordinated forelimb sensorimotor
function was performed in rats receiving unilateral intracortical
ischemic insults and cell ± SAP implants at 3 weeks (Figure 2A).
ET1-lesioned rats showed a reduced proportion of pellets eaten
with the impaired (left) paw, compared to saline-injected controls
(Figure 2A, intact, white triangles), prior to grafting, a deficit that
remained persistent and stable for 36 weeks (Figure 2A, gray tri-
angles). Limbusewas significantly improved inET1 rats receiving
cell implants (ET1 + cells: 33.8 ± 2.4%; Figure 2A, gray circles) at
36 weeks compared to controls (ET1: 22.4 ± 2.3%) and notably
more rapid in animals grafted with cells and scaffolds (ET1 +
cells+SAP), with significant improvements observed as early as
16 weeks (33.9 ± 2.4%; Figure 2A, black circles). By 36 weeks
cells+SAP implants continued to provide a significant benefit
(41.3 ± 1.3%), with limb function not different from intact controls
(41.7 ± 2.9%) and significantly greater than observed for cells
alone. Note that SAP implants, in the absence of cells, provided
no significant benefit for forelimb function, (26.0 + 3.1%; Fig-
ure 2A, white circles).
Prior to killing animals for histology, additional motor function
tests were performed. The rotarod test, a measure of balance,
coordination, and physical condition (particularly of the hin-
dlimbs), revealed no gross motor impairment resulting from
ischemia at 36 weeks (Figure 2B). In the cylinder test, a measure
of bias in limb use, ET1 and ET1 + SAP-implanted animals
showed a significant impairment in contralateral forelimb use, re-
flected by reduced weight-bearing left forepaw touches on the
cylinder wall, compared to saline-injected controls (Figure 2C).
Only ischemic animals receiving cells+SAP grafts showed a sig-
nificant improvement in left paw use compared to ET1-lesioned
rats (52.1 ± 5.5% and 26.5 ± 4.7% wall touches using left paw,
respectively), function that was not statistically separable from
intact controls (51.8 ± 2.5%). The adjusted stepping test high-
lighted forelimb akinesia in ET1-lesioned animals, as revealed
by significant reductions in left paw forehand and backhand
touches at 36 weeks, that was partially restored only in animals
receiving cells+SAP transplants (Figures 2D and 2E).
SAP Scaffolds Provide Structural and Biochemical
Support for Transplanted Cortical Progenitors in the
Ischemic Brain
At 36 weeks after receiving implants into the ischemic cortex, the
majority of animals were taken for histological analysis. HumanCell Reports 20, 1964–1977, August 22, 2017 1965
Figure 1. Generation of DDIKVAV SAP Scaffolds and hESC-Derived Cortical Progenitors Suitable for Transplantation
(A) Chemical structure of Fmoc-DDIKVAV synthesized via solid-phase peptide synthesis.
(B–E) Schematic of Fmoc-self-assembly process.
(B) Aromatic Fmoc terminal groups undergo p stacking.
(C) The DDIKVAV peptide chains undergo hydrogen bonding to form b sheets.
(D) A natural twist occurs to maintain this p-b assembly, forming a hollow nanofiber with the DDIKVAV sequence exposed on the outside of the fiber.
(E) The nanofibers interact with each other forming a nanofibrous network.
(F and G) FTIR analysis of amide I region (F) showed characteristic peak for b sheets with an observable carbamate peak, and the stable formation of a dominant
assembly confirmed by (G) circular dichroism spectroscopy, showing transition peak at 220 nm.
(H) Electron microscopic image of the Fmoc-DDIKVAV gel showing nanofibers. Scale bar, 100 nm.
(I) Rheological frequency measurements of the elastic shear moduli of storage (G’, black dots) and loss modulus (G,’’ white dots). The grey area represents the
modulus of the rat brain.
(J) Low-magnification photomicrographs of hESCs differentiated as adherent cultures under dual SMAD conditions.
(K) Inset taken from (J); high-magnification images (K’–K’’’’) illustrating that differentiation resulted in the formation of neural rosettes and ridges that were
immunoreactive for dorsal forebrain markers PAX6 (K’’), SOX2 (K’’’), and OTX2 (K’’’’) by 10 DIV.
(L and M) Cultures were subsequently expanded and matured in suspension as floating neurospheres (L), with DAPI-labeled cells (M’) immunoreactive for GFP
(M’’) and widely co-expressing NESTIN (M’’’) and OTX2 (M’’’’).
Scale bars, 100 nm (H) and 50 mm (K and M).
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Figure 2. Transplantation of hESC-Derived
Progenitors, in the Presence of SAP
Scaffolds, Improves Motor Function in
Ischemic Rats
(A–E) Comparative performance in rotarod (A),
staircase (B), cylinder (C), and adjusted stepping
(D and E) tests of control rats (intact, n = 12), and
rats subjected to unilateral ET1 lesion of the right
sensorimotor cortex (ET1, n = 20), followed by
implants at 3 weeks of SAP scaffolds (ET1 + SAP,
n = 8), hESC-derived cortical progenitor cells
(ET1 + cells, n = 12), or cell + SAP scaffold (n = 13).
(A) Time course of staircase performance in ET1
rats revealed significant improvements in pellet
retrievals using the impaired left paw by 16 weeks
in animals receiving cells+SAP implants, not
observable until 36 weeks in rats grafted with cells
alone, and absent in animals receiving SAP-only
implants.
(B) No gross motor deficits were observed in
any ET1-lesioned animals (±cell/SAP implants)
after 36 weeks, with animals displaying the ability
to remain on the rotating rod.
(C) Performance in the cylinder test revealed a persistent functional deficit in the impaired paw (% left paw touches/total touches) in ET1 and ET1 + SAP animals
at 36 weeks, that was significantly corrected in cell and cells+SAP-grafted rats.
(D and E) Performance in the stepping test, presented as number of touches with forehand (D) and backhand (E) of the left forelimb, revealed significant
improvements in limb function only in animals receiving cells+SAP transplants.embryonic stem cell (hESC)-derived cortical progenitor grafts, in
the absence or presence of SAP, could be identified within the
host cortex of ischemic rats by GFP labeling (Figures 3A and
3B). Volumetric and stereological analysis of the delineated
GFP+ grafts (implanted 3 weeks after ET1 administration) re-
vealed that grafts in the presence of SAP scaffolds were notably
larger (cells: 3.5 ± 1.8 mm3 and cells+SAP: 10.7 ± 3.8 mm3; Fig-
ures 3A–3C), correspondingly contained more DAPI+ cells (cells:
8.53 105 ± 3.63 105 and cells+SAP: 30.53 105 ± 7.53 105; Fig-
ure 3D), and thereby maintained a cellular density similar to cell-
only transplants, yet were visibly greater in density than the host
cortex (Figures 3E–3G).
To characterize morphological properties of grafts, examina-
tion of neural markers together with GFP immunoreactivity was
performed. Reflective of the ability of grafted cells to integrate
into the host tissue, and not be impeded by either the scaffold
or host scar tissue, numerous doublecortin migrating neuro-
blasts (DCN+GFP+) were observed at the edge of the grafts
and within the surrounding host parenchyma (Figure 3K). Both
cells and cells+SAP grafts contained all neural lineages including
mature neurons (NEUN+GFP+; Figure 3L), astrocytes (glial fibril-
lary acidic protein [GFAP]+GFP+; Figure 3L), and oligodendro-
cytes (OLIG2+GFP+, RIP+GFP+; Figure 3M). Cell grafts were
notably heterogeneous, containing dense patches of NEUN+
cells adjacent to regions almost devoid of neurons, resulting in
a neuronal density of 49.7% ± 8.8%. Comparatively, cell +
SAP grafts were more differentiated and homogeneous with
69.6% ± 2.9% NEUN+/GFP+DAPI+ (Figures 3H, 3N, and 3O).
We also assessed grafts for the presence of cortical layer selec-
tive neuronal populations including the T box transcription fac-
tor, TBR1 (deep layers V–VI) and POU homeodomain protein,
BRN2 (superficial layers II–IV) (Shi et al., 2012). As a proportion
of total neurons, cell grafts contained 37.6 ± 11.2% BRN2 and7.4 ± 1.1% TBR1 neurons, while cells+SAP grafts contained a
significant increase in the proportion of both BRN2 (65.8 ±
4.4%) and TBR1 (20.0 ± 2.7%) neurons (Figures 3I, 3J, and
3P–3S), suggesting the SAP scaffold impacted on the neuronal
differentiation and phenotype acquisition of the progenitors
in situ. Furthermore, in both cell and cells+SAP grafts, a dense
network of vesicular glutamate transporter (VGLUT+) glutamater-
gic fiber innervation could be observed (Figure 3T). Other
neuronal populations were relatively sparse or absent, including
g-aminobutyric acid (GABA) (Figure 3T), tyrosine hydroxylase
(TH), 5HT, and choline acetyltransferase (ChAT) (data not
shown). Interestingly, motor performance in the staircase test
at 36 weeks correlated with graft volume, total cells within the
graft (GFP+DAPI+), and proportion of neurons (including cortical
subpopulations), with those animals receiving cells+SAP im-
plants (3 weeks after ET1 administration) displaying the greatest
functional improvement and largest grafts with greatest neuronal
proportions (Figure S2) (related to Figures 2 and 3).
Graft integration was assessed at 36 weeks after implantation
by the presence and density of GFP+ fibers with the surrounding
host parenchyma. No discernable difference was observed
in the pattern of axonal growth between cells and cells+SAP-
implanted animals, with GFP+ axonal projections observed
emanating from the graft and extending long distances both ros-
tro-caudally and dorso-ventrally from the site of implantation
(Figure 4). Large bundles of GFP+ axons grew along the host
white matter of the corpus callosum (Figure 4Ci) to innervate
both the ipsi- and contralateral hemispheres. GFP+ fibers could
be observed as rostral as the olfactory bulb (data not show) and
shell of the nucleus accumbens (Figures 4A and 4Ai) and as
caudal as the midbrain (Figures 4D and 4Di). Innervation was
most prominent within the motor, somatosensory, cingulate,
piriform, and entorhinal cortex (Figures 4Bi–4Biv), reflective ofCell Reports 20, 1964–1977, August 22, 2017 1967
Figure 3. SAP Scaffolds Support hESC-Derived Progenitor Grafts and Their Cortical Neuronal Specification
(A and B) Representative photomicrographs providing a coronal projected view of a GFP-expressing human ESC-derived cortical progenitor graft, implanted at
3 weeks after ET1 administration and assessed 36 weeks later, in the absence (cells, A) and presence of an IKVAV SAP scaffolds (cells+SAP, B).
(A* and B*) High power micrographs illustrating the morphology of GFP-labeled cells at the edge of the graft.
(legend continued on next page)
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layers II–V cortical projection neurons. Networks of GFP+ fibers
were also observed in subcortical nuclei, including the hippo-
campus, lateral septum, striatum (Figures 4E, 4Bv, and 4Bvi),
and more sparsely in the ventral thalamus and hypothalamus
(Figures 4Cii and 4Ciii). Densitometric analysis of GFP-labeled fi-
bers in the motor cortex adjacent to the graft, and at distal
cortical target sites (ipsi- and contralateral entorhinal cortex),
confirmed the similarity in innervation density between cell and
cell + SAP grafts (Figure 4F).
Cortical Progenitor Grafts Are Highly Vascularized and
Show No Evidence of Neural Overgrowth 9 Months after
Transplantation
Necessary for the survival of transplanted neurons is their close
association to a vascular supply, with reports of neurons surviv-
ing poorly at distances greater than 75 mm from the nearest
blood vessel (Casper et al., 2003). In light of the large size of
the hESC-derived cortical progenitor grafts observed, we exam-
ined the extent to which the new tissue was vascularized.
RECA-1 immunostaining revealed a dense network of blood ves-
sels in both cells and cells+SAP grafts (Figures 5A and 5B) that
was not dissimilar between the two graft groups. Vessels within
grafts were significantly hypertrophied compared to the host
cortex (vessel diameter, host cortex: 18.6 ± 0.4 mm, cells graft:
35.5 ± 1.7 mm, cells ± SAP graft: 36.5 + 0.6 mm), lower in density
(area covered by RECA1+ in the host cortex: 25.4 ± 0.8%; cell
graft: 14.5 ± 1.5% and cells+SAP graft: 13.9 ± 0.7%; Figure 5C),
and likely reflect immature vessel formation and/or a feature of
vascularization of human verse rodent tissue.
Closer examination revealed that RECA1+ vessels within the
grafts were GFP (Figure 5D’) and thus host-derived. In addition,
we observed extensive RECA1+ staining of vessels within the
host tissue surrounding the graft (32.3 ± 0.4%), significantly
greater than in the cortex of unlesioned animals, and indicative
of important revascularization of the penumbra (Figures 5B’’
and 5C).
While hESCs were pre-differentiated in vitro and showed high
neural composition within the grafts (including cortical identity)
at 9 months, we importantly observed no gross morphological
features within the grafts suggestive of excessive cell division
or tumors. At 9 months, less than 0.5% of cells were dividing
(Figures 5E–5G, %Ki67/DAPI), with only occasional small Ki67+
clusters observed within the grafts, that were often GFP and
localized around RECA1+ vessels (Figure 5D’’), indicative of
host involvement in vascularization of the new tissue.(C–E) The volume of the graft core (C) commensurately increased with DAPI cell n
(F and G) Representative images showing DAPI density within cells (F) and cells+
(F’, G’, and G’’) Note cell density was not different between cell and cells+SAP g
(H–J) Quantification of NEUN+/DAPI (H), TBR1+/NEUN+ (I), and BRN2+/NEUN+ ce
and cortical specification of grafted cells in the presence of the scaffold.
(K–T) Numerous GFP+ migrating neuroblasts, expressing doublecortin (DCX), we
grafts, in the presence and absence of SAP scaffolds, contained all neural lineage
and oligodendrocytes (M). Exposure of cell grafts to SAP scaffolds significantly
specifically, the proportion of deep (BRN2+/NEUN+; P and Q), as well as super
implants. (T) Reflective of the cortical identity of transplanted neurons, cell graft
innervation (vGLUT, T’’), while other neuronal fates, including GABA (T’), were re
Data represent mean ± SEM, *p < 0.05, **p < 0.01, and ***p < 0.001. Scales bars, 1
N’, N’’, O’, and T), 25 mm (M’, T’, and T’’), and 200 mm (N and O).A challenge working with athymic nude rats over extended pe-
riods of time, particularly where excessive handling is involved
(such as for repeat surgeries and behavioral testing) is their
susceptibility to pathogens. Consequently, during the course
of the study a small number of animals were euthanized prior
to 36 weeks due to unrelated skin and intestinal-related health
concerns. These animals provided important insights into the
growth kinetics of grafts. Irrespective of graft age, and despite
the steady increases in graft volume over time (Figures S3A,
related to Figure 5), noOCT4+ cells were observed in any animals
(data not shown). Evident within younger grafts, however, was
the trend toward an increased proportion of Ki67+ dividing cells
within cells+SAP grafts at 5–7 months compared to cells alone
(Figure S3B), suggesting that the scaffold may contribute to
prolonging proliferation of the neuronal progenitor pool, a role
recently attributed to IKVAV signaling (Sahab Negah et al., 2016).
Human ESC-Derived Neurons, Grafted with SAP
Scaffolds, Develop Functional Electrophysiological
Properties in the Ischemic Cortex
To determine whether grafted cells behaved as functionally con-
nected neurons, brain slices from cells and cells+SAP-implanted
animals were taken for eletrophysiological analysis. Native GFP
fluorescence allowed for rapid identification of grafted cells (Fig-
ure 6Ai) that were patched for whole-cell recordings under Dodt
contrast (Figure 6Aii). Interestingly, SAP fibers were visible within
the slices, indicating maintained integrity of the SAP scaffold gel
at 9 months (Figure 6Aii). Patch-clamped cells were depolarized
via current injections to activate voltage-activated channels if
present. Various spiking patterns were noted in both cells and
cells+SAP-grafted tissue (Figures 6D and 6E), including regular
firing, fast spiking (Figure 6Di), and intermittent bursting (Fig-
ure 6Dii). Supported by reduced neuronal differentiation seen
in cells-only grafts were responses indicative of no voltage-acti-
vated channel expression (Figure 6Diii), a feature of immature
neurons and astrocytes. For neurons in both graft types, action
potential firing patterns were similar across various neuronal
types (Figure 6F). Cells exhibited resting membrane potentials
as follows: cell-only grafted neurons (68 ± 2 mV, n = 5), cell-
only grafted ‘‘immature neurons/astrocytes’’ (74 ± 2 mV,
n = 4), and cells+SAP-grafted neurons (61 ± 2 mV, n = 7). In
voltage clamp, we assessed pre-synaptic connectivity to neu-
rons by recording both spontaneous excitatory and inhibitory
post-synaptic currents (Figure 6G). In cell-only grafts, 4/5
recorded cells exhibited excitatory post-synaptic currentsumbers (D), resulting in no difference in the density of cells within the graft (E).
SAP grafts (G).
rafts (F’ and G’), but was notably higher than the host tissue (G’’).
lls (J) within the delineated GFP+ grafts revealed increased neuronal maturation
re observed at the graft periphery and infiltrating into the host tissue (K). Cell
s, including NEUN+ neurons and GFAP+ astrocytes (L), as well as OLIG2+, RIP+,
increased the proportion of NEUN+ cells (NEUN+/DAPI+; N and O) and, more
ficial cortical layer (TBR1+/NEUN+; R and S) neurons, compared to cell-only
s (in the presence or absence of the SAP scaffold) were rich in glutamatergic
latively sparse.
mm (A and B), 100 mm (A* and B*), 500 mm (F, G, andM), 50 mm (F’, G’, G’’, K, L,
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Figure 4. Human ESC-Derived Cortical Progenitor Grafts Display Extensive Axonal Growth along White Matter Tracts and Innervation of
Cortical Targets
(A–D) Dark field images illustrating the GFP+ graft and level of extensive axonal growth from the graft into the host brain.
(Ai and D) GFP fibers were observed throughout the rostro-caudal plane reaching targets as far rostral as the olfactory bulb and nucleus accumbens (Ai) and as
caudal as the midbrain (D).
(Bi–Biii) GFP fibers were additionally seen throughout the dorso-lateral axis of the brain, with density greatest within the ipsilateral host cortex, including themotor
(Bi), sensorimotor (Bii), and cingulate cortex, yet bundles ofGFP+fiberswere also observedcoursing through forcepsminor to innervate ventral cortical nuclei (Biii).
(Biv and Ci) Dense bundles of GFP+ fibers were observed traversing the corpus callosum (Ci) to innervate the contralateral hemisphere, where similar patterns of
cortical innervation, albeit fewer in density, were observed (Biv).
(Bv, Bvi, Cii, Ciii, and E) GFP fibers were additionally observed within subcortical nuclei including the lateral septum (Bv), striatum (Bvi), hippocampus (E),
thalamus (Cii), hypothalamus (Ciii), and midbrain (Di).
(F) Density of graft-derived GFP+ fibers within the host brain, proximal (MCtx) and distal (Ent Ctx, ipsilateral, I, and contralateral, C) to the site of implantation,
revealed no difference in patterns or density of innervation between cells and cells+SAP grafts. Mean ± SEM, Student’s t tests. Scale bars, 100 mm.
NAc, nucleus accumbens; MCtx, motor cortex; SCtx, somatosensory cortex; EntCtx, enthorinal cortex; Thal, thalamus; CPu, striatum; CC, corpus callosum;
HPC, hippocampus; MB, midbrain; hypothal, hypothalamus. Scale bars, 1 mm (A–D) and 100 mm (higher magnification insets).(EPSCs), while 3/5 exhibited inhibitory PSCs (IPSCs), suggesting
not all neurons possessed excitatory and inhibitory inputs. In
contrast, all neurons recorded from cells+SAP grafts exhibited
both EPSPs and IPSCs. The frequency and amplitude of EPSCs
and IPSCs across ‘‘connected’’ neurons were similar for cells
and cells+SAP grafts, with robust and active functions noted
(Figure 6G).
Cell Transplants in the Presence of SAP Scaffolds
ReducedCortical Atrophy, anEffect ThatWasEnhanced
by Acute Implantation after Ischemic Insult
Cortical volume was assessed in all animals to determine the
benefit of cell ± SAP implants in protecting against secondary
degeneration of the host tissue. In a small cohort of animals killed1970 Cell Reports 20, 1964–1977, August 22, 20171week after ET1 injection, the primary insult was evident by the
presence of a large necrotic lesion cavity within the sensorimotor
cortex (Figure 7E), surrounded by acellular tissue (Figure 7E’),
that without intervention resulted in significant secondary degen-
eration (32.9 ± 2.1% cortical atrophy; Figures 7A and 7F) by
36 weeks. SAP implants alone minimally protected against atro-
phy of the host tissue (28.3 ± 2.6%; Figures 7A and 7G). By
contrast, cell grafts protected the penumbral tissue and signifi-
cantly reduced atrophy (ET1 + cells, 18.6 ± 1.9%; Figures 7A
and 7H), an effect that was greatest in cells+SAP-grafted ani-
mals (11.4 ± 1.3% cortical atrophy; Figures 7A and 7I). In support
of the graft-induced protection of the host penumbra, a strong
correlation (r2 = 0.858) was observed between staircase perfor-
mance and cortical atrophy (Figure 7B).
Figure 5. Human ESC-Derived Cortical Progenitor Grafts, in the Presence or Absence of SAP Scaffolds, Are Highly Vascularized by the Host
Tissue and Show No Evidence of Tissue Overgrowth
(A–C) Representative images depicting the RECA1+ vascular network within the GFP+ cell graft of an ET-1-lesioned rat in the absence (A) and presence of a SAP
scaffold (B). RECA1+ vessels within the graft appeared hypertrophied (A’ and B’) compared to the host brain (B’’). The area covered by RECA1+ staining was
significantly reduced within the grafts compared to the intact brain, suggestive of immature vessel development, yet hypervascularization was observed in the
adjacent penumbra (C).
(D and D’) RECA+ cells within the grafts were GFP, indicative of host endothelial progenitors vascularizing the grafts (D and D’).
(D’’ and E–G) Representative image of a cell (E) and cells+SAP graft (F) showing the presence of Ki67+ proliferating cells, that were notably fewwithin the grafts (G),
and commonly associated with RECA1+ vessels (D’’), suggestive of involvement of host-derived vessel formation.
Scale bars, 500 mm (A, B, E, and F) and 50 mm (A’, B’, B’’, and D).While the majority of animals received transplants (cells ±
SAP) at 3 weeks post-ET1 lesioning to assess the impact on
functional integration and neuroprotection, an additional cohort
of animals received implants at 6 days following ET1 administra-
tion in an effort to intervene earlier in protection against second-
ary degeneration and reduce cortical atrophy. Earlier interven-
tion (at 6 days) provided no further protection against atrophy
compared to later transplantation (at 3 weeks) for either SAP or
cell-grafted animals (Figures 7A, 7G, 7H, 7J, and 7K). However,
early implants of cells+SAP significantly reduced atrophy (4.9 ±
0.8%) compared to intervention at 3 weeks (Figures 7A, 7I, and
7L). Note, graft volume and cellular composition did not signifi-
cantly vary between the two implantation times for either cells
or cells+SAP grafts (data not shown).
At 36 weeks after implantation, we quantified groups for the
density of cells within the host cortex to assess whether loss of
cortical volume correlated with neuronal loss.Within a pre-deter-
mined area adjacent to the lesion site (Figures 7D’, F’, K’, and L’),
NEUN+ neuronal density remained unchanged in saline and ET1-
treated rats (Figure 7C), indicating atrophy was proportionate to
cell loss. NEUN density within the host cortex was elevated in
cells and cells+SAP-transplanted animals, suggesting that atro-
phy of the cortex was greater than the proportion of cell loss
(Figure 7C).DISCUSSION
Promoting repair following ischemic stroke will require targeted
tissue engineering, including replacement cells, a substratum
to support the integration of new cells, protection of the sur-
rounding host, and revascularization of new and old tissue.
Here, we report that a tissue-customized self-assembling pep-
tide-based scaffold was capable of interfacing with both
replacement neurons generated from human stem cells and
residual host tissue, thereby creating a de novo tissue that
induced sustained functional recovery in an animal model of
focal ischemia.
Numerous biomaterials have been developed to model the
native three-dimensional environment of neural tissue, including
both natural and synthetic polymers assembled as nanofibers,
microspheres, or hydrogels. Such biomaterials have been
demonstrated to promote the survival, proliferation, differentia-
tion, and connectivity of neural cells in vitro (see review Rodri-
guez et al., 2012), yet have been decidedly more difficult to
deploy and assess in vivo due to their bulkiness and lack of
biocompatibility. Here, we demonstrate the practical utility of a
SAP scaffold that post-injection presents IKVAV in a nanofibrous
gel, while maintaining a modulus similar to the rat brain, and is
capable of supporting cell adhesion and axonal growth in vivo.Cell Reports 20, 1964–1977, August 22, 2017 1971
Figure 6. Human ESC-Derived Cortical Progenitors, Implanted in the Presence of SAP Scaffolds into the Ischemic Brain, Exclusively Dis-
played a Neuronal Phenotype and Enhanced Synaptic Connectivity at 9 Months
(A) Micrographs depicting GFP+ recorded cell within a rodent brain slice and the presence of SAP scaffolds at 36 weeks.
(B and C) Biocytin-filled neuron from cells (B) and cells+SAP graft (C), highlighting their mature neuronal morphology.
(Di–Diii) Depolarizing cells with current injections evoked varying response in GFP positive cells, where fast spiking (Di), intermittent bursting (Dii), and immature
neuron/astrocyte-like (Diii) responses were observed.
(E) All cells recorded in the presence of the SAP scaffold were neurons, whereas cells recorded from grafts lacking SAP scaffolds commonly exhibited immature
neuronal/astrocyte-like characteristics.
(F) Evoked action potentials (AP) were similar across neurons regardless of the presence of SAP scaffolds, although recorded cells in the absence of SAP tended
to exhibit greater variability.
(G) All neurons recorded in the presence of SAP scaffolds exhibited spontaneous excitatory and inhibitory post-synaptic currents (EPSCs and IPSCs, traces from
the same neuron). Whereas EPSCs and IPSCs were absent in some neurons patched from cell-alone grafts, indicating comparatively limited synaptic con-
nectivity. The frequency and amplitude of EPSCs and IPSCs across connected neurons were similar across cells and cells+SAP recorded cells, with robust and
active function noted.
Scale bars, 20 mm (A–C).Delivery of the biomaterial directly into the lesion cavity provided
an advantage over implantation into the already vulnerable sur-
rounding host penumbral tissue, which could lead to iatrogenic
complications. Within the injured brain, these scaffolds formed
de novo ‘‘bio-bridges’’ between the lesion cavity, implanted1972 Cell Reports 20, 1964–1977, August 22, 2017cells, and host tissue. While scaffolds alone showed minimal
protection of host tissue and function, advantages of the scaf-
folding were evident in conjunction with stem cell grafts, result-
ing in larger, more differentiated transplants than implants of
cells alone.
Figure 7. hESC-Derived Cortical Progenitor Grafts in the Presence of SAP Scaffolds Reduce Cortical Atrophy, Improving Motor Function
after Focal Ischemia
(A) Comparative assessment of percentage cortical tissue loss across the different treatment groups and of the different times of intervention (i.e., at 3 weeks,
open bars versus 6 days, striped bars). Note, earlier intervention significantly reduced atrophy in the presence of cells+SAP.
(B) Regression analyses at 36 weeks highlighted a strong negative correlation between cortical atrophy and motor function, whereby animals displaying the
greatest atrophy (ungrafted; ET1, open circles) showed the poorest performance (pellet retrievals) in the staircase test, while cell (light gray)-grafted animals
showed reduced atrophy and improved function, that was aided by the presence of scaffolds (cells+SAP, dark gray).
(C) Density of NEUN+ cells within the host cortex, adjacent to the site of injection, showed modest increases in neuronal density in cell-implanted animals,
suggestive that the extent of cortical tissue loss exceeded neuronal loss.
(D–L) Representative coronal images of NeuN staining highlighting the gross morphology of the cortex in a saline-injected rat at 36 weeks (D), and following ET-1
injection at 1 week (E), and 36weeks (F). Note the presence of the lesion cavity at 1 week and progressive cortical collapse and atrophy by 36 weeks. Implantation
of SAP scaffolds at 6 days (G) or 3 weeks (J) offered little protection against atrophy, while cell grafts in the absence (H andK) or presence of SAP scaffolds (I and L)
visibly protected the host tissue.
(D’, E’, F’, K’, L’) Higher magnification images from (D–F, K, and L) illustrating NEUN cell density. Scale bars, 2 mm (D–L) and 500 mm (D’, E’, F’, K’, and L’).In addition to the structural support provided by the scaffold
nanofibrils, which likely contributed to improved graft survival
and integration, were the benefits of tissue-specific scaffold pre-
sentation of the functional laminin epitope, IKVAV. Previous
studies have reported IKVAV, the motif from the a1 chain of the
laminin-1 peptide sequence, promotes neuronal cell attachment,
migration, differentiation, and neurite outgrowth (Cheng et al.,
2013; Silva et al., 2004; Tashiro et al., 1989), including that ofhESC-derived neurons (Ma et al., 2008). In support, here, we
report enhanced neuronal specification of hESC-derived neural
grafts in the presence of the IKVAV scaffold, as well as
augmented deep (TBR1) and superficial (BRN2) cortical layer
specification of NPCs, necessary for the replacement of neurons
lost to the primary insult. Despite the generation of cortical sub-
populations and presence of laminin signaling in the present
study, no evidence of lamination was observed. This has beenCell Reports 20, 1964–1977, August 22, 2017 1973
a common issue for cortical transplants into both the intact or
infarcted cortex and likely reflects the absence of pial and ven-
tricular surfaces, as well as radial glial cells. Such observations
highlight room for further refinement of scaffolds in an effort to
recreate such organized structures within the lesion cavity.
A key attribute of the present study was the employment
of ubiquitously expressing GFP human ESC-derived NPCs for
transplantation, enabling detailed, protracted (9 month) assess-
ment of graft composition and integration into the ischemic brain
and in the presence of a biological scaffold. The constitutive GFP
reporter line enabled detailed assessment of fiber growth pat-
terns from the graft into the surrounding host tissue. Similar to
previous reports of hPSC-derived cortical progenitors into the
intact brain (Denham et al., 2012; Espuny-Camacho et al.,
2013; Niclis et al., 2017b; Steinbeck et al., 2012), and showing lit-
tle difference in patterns of innervation between cells and cells+
SAP implants, fiber growth closely mimicked the intrinsic projec-
tions of the adult brain. Dense GFP innervation was observed
most notably within the ipsi- and contralateral cortex, yet axons
additionally extended through the external and internal capsule
to distal caudal sites, consistent with replacement of lost cortical
connections. Further studies will be required to determine the
nature of functional synaptic connectivity in these remotely
innervated brain regions. However, it is reasonable to speculate
synaptic connectivity as a likely outcome, given recent mono-
synaptic tracing and electron microscopy studies demonstrating
this as a property of transplanted neurons generated from plurip-
otent stem cells (Doerr et al., 2017; Grealish et al., 2015).
Reflective of the morphological differences observed in the
hESC-derived grafts in the absence and presence of the scaffold
(notably graft size and cortical fate) was graft function. Electro-
physiological recordings from cells+SAP-implanted animals re-
vealed all recorded cells were functional neurons and demon-
strated a higher degree of synaptic connectivity than grafts
of cells alone, as evident by the presence of both inhibitory
and excitatory inputs. In support of these findings, cells+SAP-
implanted animals showed greater improvements in motor func-
tion and/or more rapid restoration of deficits than for animals
receiving cell-only implants.
Mechanisms underlying the improvement in graft function
remain a key question in cell-based therapy for repair of the
ischemic brain. To what extent do transplanted cells provide
replacement neurons verses trophism and protection of the
host tissue? Observations of improved motor function as early
as 8 weeks post-implantation, in both cells and cells+SAP-
grafted animals, likely reflect trophism and is supported by the
reduction in host cortical atrophy, notably the enhanced pro-
tection induced by earlier intervention. Additional functional
improvement manifested between 16 and 36 weeks after graft-
ing, particularly in the cells+SAP group. This is a time frame
consistent with extensive axonal outgrowth and electrophysio-
logical maturity observed in other grafting studies (Denham
et al., 2012; Espuny-Camacho et al., 2013; Niclis et al., 2017b;
Steinbeck et al., 2012), andwas complemented by correlative in-
creases in graft size and neuronal (including cortical layer spe-
cific) differentiation, and likely reflect functional integration of
implanted neurons as a contributing therapeutic mechanism.
More detailed studies, employing engineered stem cell lines1974 Cell Reports 20, 1964–1977, August 22, 2017that can be silenced (by expressing light sensitive halorhodopsin
or designer receptors exclusively activated by designer drug
proteins), that have confirmed functional graft integration in Par-
kinson’s disease (Chen et al., 2016; Steinbeck et al., 2015), will
be required to quantitate relative contributions from cell replace-
ment and/or neuroprotection. On balance, it is important to un-
derstand the appropriate timing of transplantation after stroke
to ensure maximal survival, integration, and function. Unlike pre-
vious reports (Darsalia et al., 2011), only in animals receiving cell
grafts in the presence of the SAP scaffold was early intervention
advantageous, baring no impact on graft composition, but
importantly enhancing protection of the penumbra and high-
lighting the importance of timing as a determinant of outcome
for cell-based approaches to ischemic injury.
In summary, we report here long-term survival, integration,
and therapeutic efficacy of neural grafts embedded in a self-
assembling scaffold matrix after acute implantation into the
ischemic cortex. The results show that the use of a readily inject-
able biomaterial provides significant advantage over cells alone
when targeting the hostile environment presented by the stroke-
affected tissue and additionally facilitates the survival and matu-
ration of implanted neurons, as well as promotes substantial
axonal outgrowth. Although acute neuroprotection appears to
be the major contributing mechanism to recovery of motor func-
tion, the anatomical patterns of connectivity revealed by GFP+ fi-
ber outgrowth and the functional maturation of implanted cells
suggest that functional replacement of cortical circuitry is an
attainable goal as an additional source of therapeutic benefit.
EXPERIMENTAL PROCEDURES
Preparation of Self-Assembling Peptide Scaffolds
A tissue-specific SAP for the brains major extracellular matrix (ECM) protein,
laminin, was made using solid phase peptide synthesis (SPPS), as previously
described (Rodriguez et al., 2013). In brief, peptide synthesis was achieved by
the stepwise deprotection of the N-terminal Fmoc group of the resin-anchored
amino acid, followed by a coupling step. Two aspartate residues were incor-
porated at the N terminus of the peptide to lower the pKa and enable assembly
under physiological conditions (pH 7.4). This process of deprotection and
coupling of amino acids was repeated until the desired laminin-based epitope
was synthesized, aspartate-aspartate-isoleucine-lysine-valine-alanine-valine
(DDIKVAV; Figure 1A). Fourier transform infrared (FTIR), circular dichroism
(CD) spectroscopy, electron microscopy, and rheology were performed as
previously described to verify synthesis, structure, and modulus of the peptide
and resultant gel (Rodriguez et al., 2013, 2014). On day of use, Fmoc-SAP
powder was dissolved to 20 mg/mL in deionized water and pH corrected to
7.4. At time of implantation, the gel underwent mechanical sheering and was
mixed 1:1 with Hank’s balanced salt solution (HBSS) or cells.
Differentiation of Human Embryonic Stem Cells
The human ESC line, HES3-ENVY, constitutively expressing GFP under the
human b-actin promoter (Costa et al., 2005),was cultured and differentiated
using a dual SMAD dorsal forebrain differentiation protocol, as previously
described (Denham et al., 2012). After 17 days, neurospheres were either (1)
cryopreserved and sectioned for immunohistochemical analysis or (2) dissoci-
ated (Accutase, Invitrogen) to provide a single cell suspension (100,000
cells/mL). At the time of implantation, cells were diluted 1:1 in the hydrogel or
HBSS media to a final density of 50,000 cells/mL.
Endothelin-1-Induced Ischemia and Cell Transplantation
Animal procedures were conducted in accordance with the Australian National
Health andMedical Research Council’s published Code of Practice for the Use
of Animals in Research, and the Florey Neuroscience Institute animal ethics
committee approved experiments. Surgeries were performed on athymic
(CBHrnu) nude rats under general anesthetic (2% isoflurane). Focal ischemia
was modeled in 109 rats by unilateral injections (2 3 0.5 mL) of the vasocon-
strictor endothelin-1 (400pmol/mL,AusPep,Australia) into the right sensorimotor
cortex (0.5 and 2.0 mm anterior, 2.5 mm lateral relative to bregma, and 1.5 mm
below the dura). 12 additional rats were used as unlesioned controls, receiving
saline injections. At 6 days or 3weeks after lesioning, animals received two intra-
cortical injections (1 mL each) of hESC-derived cortical progenitor and/or SAP
gels into the lesion site (above co-ordinates). Final concentration of implanted
SAP gels was 10 mg/mL and total number of cells 100,000/rat.
Behavior
Themodified staircase test (Winkler et al., 1999) was commenced 1 week after
ET1 lesioning (T = 0 weeks, pre-graft) and repeated at 4, 8, 16, 24, and
36 weeks following implants. Rats were food-restricted for the 7 day test dura-
tion, placed in the staircase apparatus daily (Campden Instruments, UK), and
pellets retrieved and eaten recorded over 20 min. Impaired (left) paw retrievals
were expressed as a percentage of total (%L/L + R) and averaged over the last
3 test days. At T = 0 weeks, only animals capable of retrieving a minimum of 20
pellets with the unimpaired forepaw were included in the study, and only ani-
mals showing%33%of pellet retrievals with the impaired pawwere deemed to
have sufficient lesions of themotor cortex to warrant inclusion. Rotarod perfor-
mance test was conducted in rats at 36 weeks following cells ± SAP implanta-
tion. Animals were placed on a horizontal, suspended, accelerating rotating
rod (3–40 rpm) and the latency to fall (max 5 min) recorded, and each received
three consecutive trials. Cylinder test was performed at 36 weeks post implan-
tation. Animals were placed in a glass cylinder (20 cm diameter), and two ob-
servers recorded weight-bearing forepaw wall contacts (max 20 per animal,
expressed as a percentage of impaired touches/total). Stepping test was per-
formed as described previously (Olsson et al., 1995). Rats were restrained by
the experimenter, allowing them to make unilateral forepaw weight-bearing
contact with the bench, and were assessed for their ability to make stepping
adjustments with the paw when moved laterally over a 1 m distance. Number
of steps made by weight-bearing forepaws was recorded in both the forehand
and backhand direction, with testing repeated 3 times/day over 5 days.
Tissue Processing and Histology
The majority of animals were killed by an overdose of sodium pentobarbitone
(100 mg/kg) and processed for immunohistochemistry, as previously
described (Denham et al., 2012). Primary antibodies: rabbit anti-5HT
(1:1,000, Immunostar), rabbit anti-BRN2 (1:200, Santa Cruz), goat anti-choline
acetyltransferase (1:100, Millipore), goat anti-doublecortin (1:400; Santa Cruz),
rabbit anti-GFAP (1:200, Dako), chicken anti-GFP (1:1,000; Abcam), rabbit
anti-GFP (1:20,000; Abcam), mouse rabbit anti-Ki67 (1:1,000, Novocastra),
mouse anti-NEUN (1:100; R&D Systems), rabbit anti-OLIG2 (1:200, Millipore),
rabbit anti-OTX2 (1:4,000, Millipore), mouse anti-PAX6 (1:50, Developmental
Studies Hybridoma Bank [DSHB]), anti-rat endothelial cell antigen-1
(RECA-1, 1:500, Serotec), mouse anti-RIP (1:5,000, Millipore), goat anti-
SOX2 (1:200; R&D), TBR1 (1:1,000, Millipore), tyrosine hydroxylase (TH,
1:800, Pel-Freez), mouse anti-vesicular glutamate transporter 1 (vGLUT,
1:200, Millipore, MAB5504).
Assessment of Host and Graft Tissue
Atrophy and neuronal cell loss within the host cortex were quantified in control
and ET1-lesioned rats, immuno-labeled with NEUN, at 36 weeks after cell ±
SAP implants. Ipsilateral cortical atrophy was quantified from a 1:12 series,
spanning 2.7 mm rostral to 2.1 mm caudal to bregma (five sections, Figures
S1, related to 7), and expressed as a percentage of control (saline injected)
cortex. Volume was calculated from the sum of areas, section thickness,
and interval, according to Cavalieri’s principle.
NEUN cell loss was estimated from the two sections (0.8 and 1.7 mm rostral
to bregma) ventro-lateral to the infarct core (Figures 7D–7F, 7K, and 7L, see
boxed insets). Stereological counts were made in the delineated area (1.5 3
1.5 mm) at regular pre-determined intervals (2003 200 mm), within a counting
frame (40 3 40 mm), and guard zones set at 1 mm, as previously described
(Parish et al., 2001).PSC grafts were identified by GFP-labeling with volumetric assessments,
cell counts (DAPI, NEUN, BRN2, and TBR1), and densities performed stereo-
logically. Counts were made at the following pre-determined intervals (DAPI:
500 3 500 mm; NEUN: 400 3 400 mm; and TBR1 and BRN2: 280 3 280 mm)
using counting frames of known areas (DAPI: 10 3 10 mm; NEUN: 20 3
20 mm; and TBR1 and BRN2: 30 3 30 mm). For all counts, the co-efficient of
error (CE) and co-efficient of variance (CV) were calculated as estimates of pre-
cision and values of less than 0.1 were accepted (West et al., 1991).
Graft innervation of host tissue was assessed in themotor cortex adjacent to
the graft core (Figures 4B and 4Bi) and distal targets, the ipsilateral and contra-
lateral entorhinal cortex (Figures 4B, 4Biii, and 4Biv). Leica LAS Image Analysis
Software was used to estimate fiber density.
RECA-1+ vessel density was estimated from three sections/graft, with five
sites (203 magnification) randomly sampled per section, as well as five sites
within the host tissue, yet within 500 mm of the graft edge (identified by the
GFP+/GFP border), and indicative of the surrounding penumbra. Host vessel
density was additionally assessed from the contralateral hemisphere of the sa-
line-injected rats. Vessel density was expressed as the percentage total area
covered by RECA-1 staining, averaged across the sampling sites. The diam-
eter of 75 RECA-1+ vessel, randomly sampled from the three sections per
graft, as well as in the surrounding host tissue, was quantified for each brain.
Electrophysiology
Coronal forebrain slices were prepared from cells and cells+SAP-implanted
rats (n = 3/group) and whole-cell electrophysiology performed as previously
described (Denham et al., 2012; Niclis et al., 2017a). Biocytin (0.5%) was
added to the recording pipette to fill neurons after recordings, enabling
confirmation of graft origin (GFP+ cytochemistry) and visualization of cell
morphology (Figures 6B and 6C).
Statistical Analysis
Tests performed to identify significant changes between animal groups
included: repeated-measures ANOVA, one-way ANOVAs with Tukey post
hoc, and Student’s t tests. Data represent mean ± SEM, with statistical signif-
icant set at a level of 0.05, *p < 0.05, **p < 0.01, and ***p < 0.001.
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